Flavoxate Oral Syrup Suppliers & Bulk Manufacturers

Available Forms: Oral Syrup

Available Strengths: 100 mg

Reference Brands: Generic formulations marketed under different names

Category: Urology

Flavoxate is used to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination) relieve painful, frequent, or nighttime urination and urgency that may occur with infections of the prostate, bladder, or kidneys. Flavoxate is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles. Flavoxate Oral Syrup is available in Oral Syrup and strengths such as 100 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Flavoxate Oral Syrup is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Flavoxate Oral Syrup can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Flavoxate is a synthetic anticholinergic agent used for the management of urinary incontinence and overactive bladder syndrome. It works by relaxing the smooth muscles of the urinary tract, reducing bladder spasms, and alleviating symptoms such as urgency, frequency, and painful urination. Flavoxate provides symptomatic relief in conditions like cystitis, prostatitis, and other bladder irritations, making it a valuable option in urological therapy.

Available in tablet and, in some regions, syrup formulations, Flavoxate allows flexible dosing for adults and patients who have difficulty swallowing tablets. Its oral formulations are designed for ease of administration, stable dosing, and effective symptom control. Clinical experience has shown that Flavoxate is generally well tolerated and, importantly, it has not been associated with liver enzyme elevations or clinically apparent acute liver injury, highlighting its favorable safety profile.

With proven efficacy in reducing bladder muscle spasms and urinary discomfort, Flavoxate remains an essential antispasmodic therapy in urology. It is manufactured by various pharmaceutical companies globally, including both established and regional producers, and is marketed under several brand names depending on the country.